Xiaohui Ma

机构：Tasly Holding Group (China) · ORCID：0000-0001-5358-8790

发表论文 71 篇 · 总被引 2778 次 · h-index 22

代表论文

• Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism (2019 · Nature Communications · 被引 800)
• ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage (2022 · Signal Transduction and Targeted Therapy · 被引 287)
• Hyocholic acid species as novel biomarkers for metabolic disorders (2021 · Nature Communications · 被引 153)
• Anti-Adipogenic Effect of Theabrownin Is Mediated by Bile Acid Alternative Synthesis via Gut Microbiota Remodeling (2020 · Metabolites · 被引 67)
• The Effects of B1344, a Novel Fibroblast Growth Factor 21 Analog, on Nonalcoholic Steatohepatitis in Nonhuman Primates (2020 · Diabetes · 被引 56)
• Rapid determination of rosmarinic acid and its two bioactive metabolites in the plasma of rats by LC–MS/MS and application to a pharmacokinetics study (2020 · Biomedical Chromatography · 被引 26)